Halyard Health Inc (HYH) Holdings Increased by Wells Fargo & Company MN

Wells Fargo & Company MN grew its holdings in shares of Halyard Health Inc (NYSE:HYH) by 5.8% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 514,776 shares of the medical instruments supplier’s stock after buying an additional 28,265 shares during the period. Wells Fargo & Company MN owned 1.10% of Halyard Health worth $23,180,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also made changes to their positions in the company. Riverhead Capital Management LLC lifted its holdings in shares of Halyard Health by 88.1% in the 2nd quarter. Riverhead Capital Management LLC now owns 3,197 shares of the medical instruments supplier’s stock valued at $126,000 after purchasing an additional 1,497 shares during the last quarter. Victory Capital Management Inc. lifted its holdings in shares of Halyard Health by 17.7% in the 2nd quarter. Victory Capital Management Inc. now owns 4,732 shares of the medical instruments supplier’s stock valued at $186,000 after purchasing an additional 711 shares during the last quarter. Jarislowsky Fraser Ltd purchased a new stake in shares of Halyard Health in the 3rd quarter valued at about $200,000. QS Investors LLC lifted its holdings in shares of Halyard Health by 305.6% in the 2nd quarter. QS Investors LLC now owns 5,176 shares of the medical instruments supplier’s stock valued at $203,000 after purchasing an additional 3,900 shares during the last quarter. Finally, Quotient Investors LLC purchased a new stake in shares of Halyard Health in the 3rd quarter valued at about $203,000. 90.31% of the stock is owned by institutional investors.

Halyard Health Inc (NYSE:HYH) opened at $47.59 on Friday. The stock has a market capitalization of $2,228.69, a PE ratio of 22.77, a P/E/G ratio of 2.57 and a beta of 1.77. Halyard Health Inc has a 52-week low of $35.24 and a 52-week high of $50.99. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.13 and a quick ratio of 1.19.

Halyard Health (NYSE:HYH) last released its earnings results on Wednesday, November 1st. The medical instruments supplier reported $0.60 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.47 by $0.13. Halyard Health had a return on equity of 8.65% and a net margin of 3.52%. The company had revenue of $401.40 million for the quarter, compared to analysts’ expectations of $394.54 million. During the same quarter in the previous year, the firm posted $0.48 EPS. The firm’s quarterly revenue was up 1.0% on a year-over-year basis. equities analysts expect that Halyard Health Inc will post 2.08 earnings per share for the current fiscal year.

Several analysts have recently weighed in on HYH shares. Zacks Investment Research downgraded Halyard Health from a “buy” rating to a “sell” rating in a report on Wednesday, October 4th. BidaskClub upgraded Halyard Health from a “hold” rating to a “buy” rating in a research report on Saturday, August 19th. ValuEngine upgraded Halyard Health from a “hold” rating to a “buy” rating in a research report on Saturday, November 4th. KeyCorp restated a “hold” rating on shares of Halyard Health in a research report on Tuesday, October 17th. Finally, TheStreet cut Halyard Health from a “b-” rating to a “c+” rating in a research report on Monday, October 30th. Two analysts have rated the stock with a hold rating and six have issued a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $46.25.

WARNING: “Halyard Health Inc (HYH) Holdings Increased by Wells Fargo & Company MN” was reported by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are accessing this article on another website, it was illegally stolen and reposted in violation of US and international trademark and copyright laws. The original version of this article can be viewed at https://ledgergazette.com/2017/12/17/halyard-health-inc-hyh-holdings-increased-by-wells-fargo-company-mn.html.

Halyard Health Company Profile

Halyard Health, Inc is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.

Institutional Ownership by Quarter for Halyard Health (NYSE:HYH)

Receive News & Ratings for Halyard Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply